Search

everythinglearnresearchcommunity

for

Search:↓

There are no FDA-approved treatments for Alopecia Areata, and current options have varying success and relapse rates.

Frontal fibrosing alopecia causes hairline recession and eyebrow loss in postmenopausal women.

Intralesional triamcinolone acetonide can regrow hair in alopecia areata but often has temporary effects and side effects.

Intralesional triamcinolone acetonide is more effective than platelet-rich plasma for treating scalp alopecia areata.

Intralesional triamcinolone acetonide effectively treats alopecia areata, as shown by significant improvements in hair regrowth and dermoscopic indicators.

Mixing platelet-rich plasma with triamcinolone acetonide can potentially improve hair regrowth in alopecia areata patients.

Start with 2.5 mg/mL triamcinolone acetonide for scalp alopecia areata and increase if needed.

Intralesional steroids are more effective for hair regrowth in alopecia areata than NBUVB, but combining them doesn't improve results.

Fractional CO2 laser with topical triamcinolone is more effective and safer for treating alopecia areata than intralesional triamcinolone.

Intralesional triamcinolone acetonide is better than PRP for treating scalp alopecia areata, leading to faster and more complete hair regrowth.

Intralesional triamcinolone acetonide is more effective but has a higher relapse rate than platelet-rich plasma for treating alopecia areata.

Steroid injections are more effective than platelet rich plasma for treating patchy hair loss.

A patient experienced permanent hair loss due to an allergic reaction to a corticosteroid injection.

Intralesional triamcinolone effectively reduces pain and inflammation in hidradenitis suppurativa flares.

Intralesional triamcinolone acetonide can effectively limit the progression of GLPLS.

Combining epinephrine with a steroid may help regrow hair in severe alopecia areata cases.

Both treatments for localized alopecia areata are equally effective.

Patients treated with long-term intralesional corticosteroids for alopecia areata should be monitored for bone density changes and advised on osteoporosis prevention.

Intralesional steroids can help regrow hair in some alopecia areata patients but have side effects.

The patient's hair loss from alopecia totalis returned despite initial successful treatment.

Some treatments can help with a hair loss condition called alopecia areata, but none ensure lasting results; choices depend on the person, with JAK inhibitors showing promise for severe cases.

There are many treatments for permanent hair loss disorders, but their effectiveness varies and there's no clear best option.

The paper concludes that recognizing bitemporal alopecia areata is important for early treatment and preventing its progression.

The treatment helped reduce symptoms and stabilize the hairline in most patients with Frontal Fibrosing Alopecia, but hair regrowth was limited.

Intramuscular corticosteroids are effective and safe for severe alopecia areata, with most patients regrowing hair, but nearly half may relapse.

PRP shows promise for treating mild alopecia areata but needs more research for cicatricial alopecias.

The combined treatment helps improve severe hair loss and reduces the need for other medications.

Early diagnosis and treatment of nail lichen planus in children can prevent permanent nail damage.

Most patients improved with oral antibiotics, but some needed long-term treatment or had minimal response.

Alopecia areata can be managed with various treatments, and severe cases should be referred to dermatologists.